BOLTON SECURITIES CORPORATION’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.3K	Buy	+1,000	New	+$65.2K	﹤0.01%	1296

Other funds holding SBIO

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Silver Oak Securities Jackson, Tennessee $1.36B AUM 21.31% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's SBIO Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q3 2026: 1,000 shares worth $58.3K. The stake represents ﹤0.01% of the portfolio and ranks #1296 among its holdings.

49 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

BOLTON SECURITIES CORPORATION held 1,000 shares of ALPS Medical Breakthroughs ETF worth $58.3K as of Q3 2026.
ALPS Medical Breakthroughs ETF was a new BOLTON SECURITIES CORPORATION position in Q3 2026.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1296 holding.
49 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.